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Generalized borreliosis with CNS and joints involvement
was diagnosed.
Case 3: A 31 years old woman presented severe pain
NCS=8 points in anterior femoral region. No tick bite was
noticed. EM was recognized. Analgesic treatment did not
cause any alleviation of pain. Physical examination showed
skin paresthesia corresponding to region of pain. The anti-
bodies against B.b. were detected in serum, conﬁrmed by
W.b. assay. Femoral nerve radiculopathy in course of neu-
roborreliosis was diagnosed. All patients were treated with
antibiotics: ceftriaxone.
Conclusion: In cases, when pathomechanism of pain is
difﬁcult to understand, neuroborreliosis should be included
as one of differential diagnosis. The real diagnosis and
treatment result in complete withdrawal of pain and other
clinical symptoms.
doi:10.1016/j.ijid.2010.02.506
HIV: Opportunistic Infections & Malignancies (Poster
Presentation)
78.001
The emerging of non-AIDS related neoplasms in the era of
combined antiretroviral therapy
R. Manfredi
University of Bologna, Bologna, Italy
Background: The introduction of combined antiretroviral
therapy (cART) since the year 1996, contributed to a rapid,
signiﬁcant drop of frequency of all AIDS-deﬁning opportunis-
tic infections and some selected AIDS-related tumors (like
Kaposi’sarcoma), with a consequent, remarkable reduction
of both morbidity and mortality rates associated with these
disease complications.
Methods: Our cohort of over 1,700 HIV-infected patients
followed in two connected outpatient centres by the
same physician staff were prospectively followed since
the year 2000 (9 years), with special interest focused on
the diagnosis, treatment and outcome of non-AIDS related
malignancies.
Results: Among hematological malignancies other than
non-Hodgkin’s lymphoma and primary central nervous
system lymphoma, we observed three cases of acute myel-
ogenic leukaemia and 4 episodes of Hodgkin’s lymphoma. A
greater number of solid tumors involved different organs
and sites: laryngeal cancer (8 cases, with 6 episodes of
papillomatous laryngeal cancer), rhinopharyngeal squamous
carcinoma (4 cases), adenocarcinoma of the lung (6 cases),
gastric adenocarcinoma (3 episodes), esophageal carcinoma
(2 patients), prostate cancer (4 cases), bladder adnocar-
cinoma (3 episodes) pancreatic adenocarcinoma (2 cases),
and squamos anal carcinoma (2 episodes). Some of these
malignancies have been reported with extremely rare fre-
quency until now (usually as single-case anecdotal reports),
in particular before the cART era. The patient’s age ranged
from 34 to 67 years, the mortality rate of these episodes
was very elevated (over 80%), and occurred 3-41 months
after diagnosis, despite appropriate surgical and/or cyto-
toxic chemotherapy and/or radiotherapy.
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Conclusion: The signiﬁcantly increased life expectancy
f HIV infected patients in the cART era was charac-
erized by a proportionally increase of non-AIDS-deﬁning
umors, which may depend on the advanced mean patients’
ge, their prolonged exposure to risk factor, the persist-
ng functional immune system imbalance, and probably
ome direct oncogenic property of HIV itself, even when
‘‘quantitative’’ recovery of CD4+ lymphocyte count has
een achieved thanks to cART. The differential diagnosis
f non-AIDS-associated tumors may be delayed by the low
linical suspicion, and their frequency to mimick and/or
verlap infectious complications. Further epidemiological
nd clinical investigation is strongly warranted, to increase
he awareness of this emerging phenomenon.
oi:10.1016/j.ijid.2010.02.507
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he role of the tuberculosis in outcome and treatment
ailure in HIV-infected Cambodian children
. Krcmery ∗, B. Irad, J. Vujcikova, E. Mitterpachova, A.
alavska, P. Kisac
St. Elizabeth University College of Health and Social Sci-
nces, Bratislava, Slovakia
Background: Tuberculosis and AIDS are considered to be a
‘deadly synergy’’ among HIVinfected children in Southeast
sia and sub-Saharan Africa.
Methods: We have assessed a cohort of 118 HIV-infected
hildren, 72 of them receive antiretroviral therapy (HAART)
or an average of 38 months (12-63 months), for the preva-
ence of tuberculosis, anti-tuberculosis therapy, immune
esponse to HAART and coincidence of other opportunistic
nfections. Table 1 shows a cohort of 40 HIV-infected chil-
ren with tuberculosis (36 pulmonary and 4 extrapulmonary)
ompared to 32 HIV — infected children without tuberculosis
ut with AIDS and other opportunistic infections.
Results: Children with tuberculosis were signiﬁcantly
ounger (P<0.01) (7.8 vs. 12.8 years) and had signiﬁcantly
ower CD4 absolute count (180 vs. 302) in comparison to
IV-infected children without tuberculosis. Immune cate-
ory 3 (82.5% vs. 59,4%, P<0.05) and CDC category C (45% vs.
.4%, P<0.001) were also more frequently observed among
IV-infected children with tuberculosis.
Proportion of deaths (3 children within 5 years within
2 children on HAART) or treatment failure on 1-st line
AART (6 children) was similar in both groups of children
with tuberculosis and without tuberculosis). Frequency of
pportunistic infections (more than 5 per year) among tuber-
ulosis children cohort was also higher among tuberculosis
IV-infected children (70% vs. 21,9%, P<0.001). Otitis media
55% vs. 31,1% P<0.05), oropharyngeal candidiasis (45% vs.
1,9% P<0.04), Immune reconstruction syndrome (IRS) (40%
s. 12,5%, P<0.001) occurred signiﬁcantly more frequently
n HIV-infected children with tuberculosis in comparison to
hildren without tuberculosis. Anti tuberculosis treatment
Isoniazide + Rifampin + Pyrazinamid) was given 4-8 weeks
efore onset of HAART (lamivudine + didanosin + efavirens),
o decrease the probability of IRS. Most children received 6
onths treatment with Isoniazide + Rifampin + Pyrazinamid
60%) or Ethambutol (40% children older than 10 years), 7-9
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Conclusion: Co-infection has limited impact on immuno-
logic and virologic outcomes, but may be an important cause
of hepatotoxicity.
doi:10.1016/j.ijid.2010.02.510400 14
onths received 30% of children and 10 — 12 months 20% of
hildren (extrapulmonary tuberculosis or treatment failure).
Conclusion: In conclusion, occurrence of several oppor-
unistic infections decreased absolute CD4 count, immune
econstruction syndrome, younger age, severe anaemia,
ore than 5 opportunistic infections within 6 months, CDC
ategory C and immune stage 3 were signiﬁcantly associated
ith tuberculosis in HIV-infected children.
oi:10.1016/j.ijid.2010.02.508
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IDS-associated mycobacterial infections in a large urban
ospital during the HAART era (2003-2006)
. Sanche1,∗, M. Nguyen2
Keck School of Medicine, Los Angeles, CA, USA
University of Southern California, Los, Angeles, CA, USA
Background: Mycobacterial infections in HIV are well rec-
gnized. The aim of this study is to describe mycobacterial
nfections in HIV positive patients in a large urban setting
ith a large immigrant population in the HAART era by
ssessing mycobacterial species prevalence, clinical param-
ters, radiological ﬁndings, and survival rates.
Methods: All mycobacterial cultures reported positive at
os Angeles County-University of Southern California Hos-
ital from 2003 to 2006 were reviewed and their respective
linical charts analyzed. This descriptive retrospective study
as approved by our local Institutional Review Board.
Results: From 2003 to 2006, 965 mycobacterial isolates
ere obtained from 814 patients. Of these, 201 (25%) of
he patients were HIV positive and accounted for 262 (27%)
f the isolates. The average age of the patients was 42
ears and the male:female ratio was 166:35. 65% of the
atients’ country of origin was outside the United States.
he mean CD4 count was 137 cells/mm3 and approxi-
ately 25% of patients were receiving antiretrovirals at the
ime of mycobacterial diagnosis. Of the HIV positive iso-
ates, 30% were Mycobacterium tuberculosis and 70% were
on-tuberculosis mycobacterial infections [Mycobacterium
vium (39%), M. ﬂavascens (1%), M. fortuitum (11%), M.
ordonae (12%), M. kansasii (3%), M simiae (2%), M. ter-
ae (0.8%), and M. xenopi (0.4%)]. For the Mycobacterium
uberculosis and the non-tuberculous mycobacteria, the
ody sites from which the isolates were obtained included
ulmonary (64% and 80%), gastrointestinal (10% and 7%),
kin/soft tissue (18% and 4%), hematologic (1% and 8%), cen-
ral nervous sytstem (5% and 0.5%) and genitourinary (1% and
.5%) respectively. 83% of all patients had abnormal chest
adiographs. 3% of the M. tuberculosis isolates were multi-
rug resistant. The survival rate of patients was 91% at 6
onths, and 49 of the patients were lost to follow up.
Conclusion: Unlike previous studies that report M. tuber-
ulosis species as the predominate strain in AIDS-associated
nfections our survey demonstrated that Mycobacterium
vium infections are the most common. This has clinical
mplications when treating AIDS patients with a positive
cid-fast culture as the identiﬁcation of the specimen is
ade.
oi:10.1016/j.ijid.2010.02.509ternational Congress on Infectious Diseases (ICID) Abstracts
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prospective cohort study of immunologic and virologic
utcomes in patients with HIV/AIDS and hepatitis virus co-
nfection in Jos, Nigeria
. Isa1,∗, L.N. Gwamzhi2, C. Akolo3, C. Ukoli 4
Federal Staff Hospital, Garki II, Abuja, Nigeria
Grenada General Hospital, St Georges, St George’s,
renada
SRA International Inc, Rockville, MD, USA
Jos University Teaching Hospital, Jos, Plateau, Nigeria
Background: In the era of highly active antiretroviral
herapy (HAART), hepatitis B and C virus (HBV and HCV) co-
nfection have emerged as signiﬁcant co-morbid conditions.
ocal reports indicate that co-infection is not uncommon in
igeria as in other sub-Saharan African countries. Whether
reatment outcomes of HIV mono-infected patients differ
rom those with co-infection remains largely unknown. We
ypothesised that co-infected patients will have lower CD4+
ount recovery and viral load reduction following HAART.
Methods: A cohort study in antiretroviral therapy-naïve
IV-infected adults involving 150 cases (HIV and hepati-
is co-infection) and 150 controls (HIV infection only).
atients’ care was according to the National guidelines
nd patients received ﬁrst line therapy mostly comprising
amivudine, Stavudine and Nevirapine. Additionally, abdom-
nal ultrasound and prothrombin time tests were done when
ecessary. Medication adherence was monitored using phar-
acy log system, and CD4+ cell counts and HIV viral load
VL) were compared at baseline, 3 and 6 months of therapy.
Results: There were 98(65.3%) and 96(64%) female cases
nd controls (p=0.79) respectively. The mean ages of cases
nd controls were 38±8.4 and 37±8.9 years (p=0.20) respec-
ively. Cases comprised 73(48%) HBV, 70(47%) HCV and 7(5%)
ith HBV plus HCV infection. Medication adherence was
95% in both arms. Attrition rate was 2.7%(8); seven of
hese were co-infected. Five cases (3.3%) compared to zero
ontrols developed clinical hepatitis. The proportions of
atients with CD4+ count <200 cells/!l among cases and
ontrols were 111(74%) and 109(72%), p=0.36 at baseline;
6(45.5%) and 64(42.7%), p=0.21 at 3 months; 60(42%) and
6(37.6%), p=0.40 at 6 months respectively. Signiﬁcantly,
ore controls (60.7%) had CD4+ increases ≥50cells/l at
months compared to 37(54.5%) HCV+ cases (p=0.03). No
igniﬁcant difference in CD4+ counts between controls and
ases at 6 months. The baseline median VL for cases and con-
rols were log104.95 and log104.83 (p=0.17) respectively.
he proportions of cases and controls with undetectable VL
t 3 and 6 months were 96(66.2%) and 97(65.5%); p=0.74,
nd 116(81.1%) and 97(79.3%); p=0.10 respectively.
